IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 276-300 out of 1364.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

Public Release: 27-May-2015
State regulations for indoor tanning could lead to a national regulatory framework
A national regulatory framework designed to prevent and limit indoor tanning is needed to alleviate the cancer burden and reduce the billions in financial costs from preventable skin cancer, say two Georgetown University public health experts.

Contact: Karen Teber
Georgetown University Medical Center

Public Release: 27-May-2015
British Journal of Cancer
Eating a Mediterranean diet could cut womb cancer risk
Women who eat a Mediterranean diet could cut their risk of womb cancer by more than half (57 percent), according to a study published Wednesday in the British Journal of Cancer.

Contact: Emily Head
Cancer Research UK

Public Release: 27-May-2015
Science Translational Medicine
Programming probiotics for early detection of liver cancer metastases
Scientists at the University of California, San Diego and the Massachusetts Institute of Technology have described a new method for detecting liver cancer metastases in mice. The approach uses over-the-counter probiotics genetically programmed to produce signals easily detectable in urine when liver cancer metastases are present.
Ludwig Center for Molecular Oncology at MIT

Contact: Ioana Patringenaru
University of California - San Diego

Public Release: 27-May-2015
Annals of Family Medicine
False breast cancer alarm has negative impact on health
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine. Researchers call for improving screening accuracy, thus reducing the number of false-positive mammograms.

Contact: Bruno Heleno
University of Copenhagen The Faculty of Health and Medical Sciences

Public Release: 27-May-2015
Scientists identify key to preventing secondary cancers
Leading scientists from the University of Sheffield and University of Copenhagen have identified a possible key to preventing secondary cancers in breast cancer patients, after discovering an enzyme which enhances the spread of the disease.
Breast Cancer Campaign, Cancer Research UK, Novo Nordisk Foundation, Danish Cancer Society, Lundbeck Foundation, University of Sheffield, University of Copenhagen

Contact: Amy Pullan
University of Sheffield

Public Release: 26-May-2015
Pitt team IDs two new, very large classes of RNAs linked to cancer biomarker
Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in June issue of the scientific journal RNA
Mathers Foundation, National Institutes of Health, American Cancer Society, Deutsche Forschungsgemeinschaft, the European Research Council, Bavarian Genome Research Network

Contact: Anita Srikameswaran
University of Pittsburgh Schools of the Health Sciences

Public Release: 26-May-2015
Beliefs about complementary and alternative medicine predict use among patients with cancer
A new study has shed light on how cancer patients' attitudes and beliefs drive the use of complementary and alternative medicine.

Contact: Evelyn Martinez

Public Release: 26-May-2015
Study finds association between exposure to aflatoxin and gallbladder cancer
In a small study in Chile that included patients with gallbladder cancer, exposure to aflatoxin (a toxin produced by mold) was associated with an increased risk of gallbladder cancer, according to a study in the May 26 issue of JAMA.

Contact: Catterina Ferreccio
The JAMA Network Journals

Public Release: 26-May-2015
Nature Communications
Therapy-resistant breast cancer mechanism revealed
Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance. The work was published in Nature Communications on April 29th, 2015.
CREST of Japan Science and Technology Agency, Grant-in-Aid for Scientific Research, and others

Contact: Naoko Fukuda
Kumamoto University

Public Release: 26-May-2015
Journal of Clinical Oncology
World first as viral immunotherapy for skin cancer shows patient benefit in phase III trial
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown. It is the first time that a phase III trial of viral immunotherapy has definitively shown benefit for patients with cancer.

Contact: Henry French
Institute of Cancer Research

Public Release: 26-May-2015
Science Signaling
Study suggests using excess stress to kill therapy resistant breast cancer
Maxing out the inherently stressed nature of treatment-resistant breast cancer cells thwarts their adaptive ability to evolve genetic workarounds to treatment, according to a study published May 26 in Science Signaling. Looking at tumor progression as essentially an evolutionary process, researchers highlight the feasibility of maximizing cell stress by inhibiting adaptive pathways to cause cell death.

Contact: Nick Miller
Cincinnati Children's Hospital Medical Center

Public Release: 26-May-2015
Genes to Cells
Protein scaffold
OIST researchers chart a protein that scaffolds the chromosome along its length to help perpetuate life.

Contact: Kaoru Natori
Okinawa Institute of Science and Technology (OIST) Graduate University

Public Release: 26-May-2015
2015 ASCO Annual Conference
Melanoma, pediatric cancer and lymphoma dominate research from NYU Langone at ASCO 2015
NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster and publication presentations.

Contact: Jim Mandler
NYU Langone Medical Center / New York University School of Medicine

Public Release: 26-May-2015
Bone Marrow Transplantation
Clinical trial reduces stress of cancer caregivers
A randomized control trial funded by the National Cancer Institute by members of the University of Colorado Cancer Center, published in the journal Bone Marrow Transplantation, demonstrates an intervention that successfully reduces the stress of caregivers in the context of cancer patients treated with stem cell transplantation.
NIH/National Cancer Institute, National Institutes of Health

Contact: Garth Sundem
University of Colorado Anschutz Medical Campus

Public Release: 25-May-2015
Proceedings of the National Academy of Sciences
Ovarian cancer-specific markers set the stage for early diagnosis, personalized treatments
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have now identified six mRNA isoforms (bits of genetic material) produced by ovarian cancer cells but not normal cells, opening up the possibility that they could be used to diagnose early-stage ovarian cancer. What's more, several of the mRNA isoforms code for unique proteins that could be targeted with new therapeutics.
National Cancer Institute, Colleen's Dream Foundation

Contact: Heather Buschman
University of California - San Diego

Public Release: 25-May-2015
Nature Genetics
Researchers unveil new gene subgroup in prostate cancer
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it. The discoveries, published online today in Nature Genetics, are a further step along the road to personalizing prostate cancer medicine say study co-leads, Dr. Robert Bristow, a clinician-scientist at Princess Margaret Cancer Centre, and Dr. Paul Boutros, an investigator at the Ontario Institute for Cancer Research.
Movember Foundation, Prostate Cancer Canada, Ontario Institute for Cancer Research, Government of Ontario, Princess Margaret Cancer Foundation

Contact: Erica Di Maio
416-946-4501 x4011
University Health Network

Public Release: 25-May-2015
Very overweight teens may double their risk of bowel cancer in middle age
Being very overweight in your teens may double the risk of developing bowel cancer by the time you are middle aged, suggests research published online in the journal Gut.

Contact: Gozde Zorlu

Public Release: 25-May-2015
Molecular Cell
A scientific breakthrough helps explain how DNA is organized in our cells
A team of researchers at the IRCM led by François Robert, Ph.D., uncovered a critical role for two proteins in chromatin structure. Their breakthrough, recently published in the scientific journal Molecular Cell, helps explain how DNA is organized in our cells. This discovery could lead to a better understanding of what causes certain types of cancer, such as lymphoma.
Canadian Institutes of Health Research, L'Oréal-UNESCO for Women in Science Research Excellence

Contact: Julie Langelier
Institut de recherches cliniques de Montreal

Public Release: 25-May-2015
ACS Nano
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies
Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through 'virtual biopsies' and then attack the molecular structure of the disease.
National Institutes of Health, Arrogene Inc. and Martz Translational Breast Cancer Research Fund, NIH/National Cancer Institute

Contact: Sandy Van
Cedars-Sinai Medical Center

Public Release: 23-May-2015
54th Annual PTCOG Conference
New survey shows 36-percent increase in pediatric patients treated with proton therapy
Results from a new nationwide survey led by Scripps Proton Therapy Center indicate a steady increase in the number of pediatric patients who are being treated with proton radiation therapy for cancerous and non-cancerous tumors. Based on a survey of all proton therapy centers in the United States, the number of pediatric patients treated with proton therapy grew to 722 in 2013, a 36-percent increase from the 465 patients treated in 2010.

Contact: Steve Carpowich
Scripps Health

Public Release: 22-May-2015
Annual Conference of the Particle Therapy Cooperative Group
New study finds that proton therapy has fewer side effects in esophageal cancer patients
New research has found that esophageal cancer patients treated with proton therapy experienced significantly less toxic side effects than patients treated with older radiation therapies.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 22-May-2015
Radiation Research
New research leads to FDA approval of first drug to treat radiation sickness
New research has led the FDA to approve use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 22-May-2015
Nature Communications
This Slinky lookalike 'hyperlens' helps us see tiny objects
It looks like a Slinky suspended in motion. Yet this photonics advancement -- called a metamaterial hyperlens -- doesn't climb down stairs. Instead, it improves our ability to see tiny objects.
US Army Research Office, National Science Foundation

Contact: Cory Nealon
University at Buffalo

Public Release: 21-May-2015
BMC Cancer
Brain tumors: Millimeter by millimeter towards a better prognosis
A method known as navigated transcranial magnetic stimulation (nTMS) has been gaining importance in neurosurgery for some time now. Among other applications, it is used to map brain tumors before an operation and to test whether important regions of the brain, for example motor and language areas, are affected. Doctors at the Technische Universität München have now shown that preoperative nTMS analysis of motor areas improves the prognosis of patients with malignant brain tumors.

Contact: Vera Siegler
Technical University of Munich (TUM)

Public Release: 21-May-2015
Environmental Research
Fine particulate air pollution associated with increased risk of childhood autism
Exposure to fine particulate air pollution during pregnancy through the first two years of the child's life may be associated with an increased risk of a child developing autism spectrum disorder, a condition that affects one in 68 children, according to a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.
Heinz Endowments

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Showing releases 276-300 out of 1364.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

  Search News Releases